Cite
HARVARD Citation
Sathish, J. et al. (2022). Comprehensive Nonclinical Safety Assessment of Nirmatrelvir Supporting Timely Development of the SARS-COV-2 Antiviral Therapeutic, Paxlovid™. International journal of toxicology. pp. 276-290. [Online].